Literature DB >> 10212125

N6,5'-Disubstituted adenosine derivatives as partial agonists for the human adenosine A3 receptor.

E W van Tilburg1, J von Frijtag Drabbe Künzel, M de Groote, R C Vollinga, A Lorenzen, A P IJzerman.   

Abstract

5'-(Alkylthio)-substituted analogues of N6-benzyl- and N6-(3-iodobenzyl)adenosine were synthesized in 37-61% overall yields. The affinities of these compounds for the adenosine A1, A2A, and A3 receptors were determined using rat brain cortex, rat brain striata, and stably transfected human A3 receptors in HEK 293 cells, respectively. The compounds proved to be selective for the adenosine A3 receptor and displayed affinities in the nanomolar range. Compounds 8, 10, and 11 had the highest affinities for the A3 receptor with Ki values ranging from 8.8 to 27.7 nM. In the N6-benzyl series, compound 4 (LUF 5403), with a 5'-methylthio group, maintained a reasonable affinity and had the highest selectivity for the A3 receptor. Compound 12 (LUF 5411), with an N6-(3-iodobenzyl) group and a 5'-(n-propylthio) substituent, had the highest A3 selectivity of all of the compounds and also displayed high affinity for this receptor (Ki = 44.3 nM). The compounds were also evaluated for their ability to stimulate [35S]GTPgamma[S] binding in cell membranes expressing the human adenosine A3 receptor. It appeared that the N6,5'-disubstituted adenosine derivatives behaved as partial agonists. Compounds 2, 4, 8, and 10 had the highest intrinsic activities. Additionally, when tested in a cAMP assay, these compounds also behaved as partial agonists.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10212125     DOI: 10.1021/jm981090+

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  14 in total

1.  Structure-guided design of a methyl donor cofactor that controls a viral histone H3 lysine 27 methyltransferase activity.

Authors:  Jiaojie Li; Hua Wei; Ming-Ming Zhou
Journal:  J Med Chem       Date:  2011-10-12       Impact factor: 7.446

2.  Docking studies of agonists and antagonists suggest an activation pathway of the A3 adenosine receptor.

Authors:  Soo-Kyung Kim; Zhan-Guo Gao; Lak Shin Jeong; Kenneth A Jacobson
Journal:  J Mol Graph Model       Date:  2006-05-09       Impact factor: 2.518

3.  Functional selectivity of adenosine A1 receptor ligands?

Authors:  Ellen V Langemeijer; Dennis Verzijl; Stefan J Dekker; Ad P Ijzerman
Journal:  Purinergic Signal       Date:  2012-09-28       Impact factor: 3.765

4.  (N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists.

Authors:  Susanna Tchilibon; Bhalchandra V Joshi; Soo-Kyung Kim; Heng T Duong; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2005-03-24       Impact factor: 7.446

5.  Allosteric modulation, thermodynamics and binding to wild-type and mutant (T277A) adenosine A1 receptors of LUF5831, a novel nonadenosine-like agonist.

Authors:  Laura H Heitman; Thea Mulder-Krieger; Ronald F Spanjersberg; Jacobien K von Frijtag Drabbe Künzel; Alessandro Dalpiaz; Adriaan P IJzerman
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

6.  Topological sub-structural molecular design (TOPS-MODE): a useful tool to explore key fragments of human A3 adenosine receptor ligands.

Authors:  Liane Saíz-Urra; Marta Teijeira; Virginia Rivero-Buceta; Aliuska Morales Helguera; Maria Celeiro; Ma Carmen Terán; Pedro Besada; Fernanda Borges
Journal:  Mol Divers       Date:  2015-07-24       Impact factor: 2.943

Review 7.  Structure-based approaches to ligands for G-protein-coupled adenosine and P2Y receptors, from small molecules to nanoconjugates.

Authors:  Kenneth A Jacobson
Journal:  J Med Chem       Date:  2013-05-09       Impact factor: 7.446

8.  Neoceptor concept based on molecular complementarity in GPCRs: a mutant adenosine A(3) receptor with selectively enhanced affinity for amine-modified nucleosides.

Authors:  K A Jacobson; Z G Gao; A Chen; D Barak; S A Kim; K Lee; A Link; P V Rompaey; S van Calenbergh; B T Liang
Journal:  J Med Chem       Date:  2001-11-22       Impact factor: 7.446

9.  N6-Substituted adenosine derivatives: selectivity, efficacy, and species differences at A3 adenosine receptors.

Authors:  Zhan-Guo Gao; Joshua B Blaustein; Ariel S Gross; Neli Melman; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2003-05-15       Impact factor: 5.858

Review 10.  Partial agonists for A(3) adenosine receptors.

Authors:  Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Curr Top Med Chem       Date:  2004       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.